Jubilant Chairman Cleared of Charges in Sexual Assault Case

Published On 2025-04-22 13:37 GMT   |   Update On 2025-04-22 13:37 GMT
Advertisement

New Delhi: Jubilant Pharmova Limited has officially announced that the allegations made against its Chairman, Shyam S Bhartia have been found to be "baseless and false," as per a closure report submitted by the police and accepted by the court.

The update was communicated to the stock exchanges, BSE and NSE, on April 20, 2025, under Regulation 30(11) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015​.

The development follows a disclosure made by the company on February 25, 2025, regarding certain media reports on the registration of a First Information Report (FIR) concerning allegations against Bhartia. The company had previously clarified that the case did not have any material impact on its business operations.

Also Read: Jubilant Pharmova Arm Salisbury Facility Gets USFDA EIR

In its recent update, the company stated, "The Police officials have filed a Closure Report as the allegations against him have been found to be baseless and false. The Hon’ble Court after examining the Closure Report and the statements given by the Complainant has passed an Order accepting the said Closure Report. Therefore, there is no case against Mr. Shyam S. Bhartia."

As per a media report in The Indian Express, allegations of rape and money fraud were levelled against Bhartia and one of his associates by a Bollywood actress.

Lately, the latest order effectively clears Bhartia of all charges. The company also reiterated that Bhartia, in his personal capacity, had earlier denied all allegations, terming them as, “Baseless, false and disparaging.”

The company emphasized that these proceedings had no material impact on Jubilant Pharmova's operations.

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News